Alison Fleig, PA
Physician Assistant · Toledo, OHNPI 1013312693
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,006 of the $47,829 with a category attached, or 85.7%. 42 manufacturers reported payments, led by Insulet Corporation at 42.6% of the total. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 588 payments — averaging $81.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$20K
- Medtronic$16K
- Tandem Diabetes Care, Inc.$6K
- Novo Nordisk$1K
- Lilly USA, LLC$709
- Dexcom, Inc.$554
- plus $3K from 36 others
What the payments were for
- Speaking & faculty fees$41,00686%
- Food & beverage$6,58314%
- Gifts$2401%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 82 | $20,367 |
| Medtronic | 40 | $15,563 |
| Tandem Diabetes Care, Inc. | 48 | $6,061 |
| Novo Nordisk | 121 | $1,095 |
| Lilly USA, LLC | 47 | $709 |
| Dexcom, Inc. | 62 | $554 |
| Amgen | 23 | $375 |
| Boehringer Ingelheim | 19 | $352 |
| Corcept Therapeutics | 12 | $348 |
| Antares Pharma, Inc. | 15 | $272 |
| Recordati_rare_diseases_inc. | 12 | $199 |
| Novartis | 8 | $188 |
| Sanofi-aventis U.S. LLC | 10 | $167 |
| Xeris Pharmaceuticals, Inc. | 7 | $145 |
| Mannkind Corporation | 7 | $139 |
| Abbott | 7 | $123 |
| AstraZeneca(2 entities) | 9 | $123 |
| Amarin Pharma, Inc. | 7 | $123 |
| Halozyme Inc | 5 | $86 |
| Nevro Corp. | 3 | $83 |
| Vivus LLC | 4 | $77 |
| Esperion Therapeutics, Inc. | 5 | $77 |
| Ascendis Pharma Endocrinology Inc | 4 | $72 |
| Sequel Med Tech, LLC | 3 | $61 |
| Ascensia Diabetes Care US Inc. | 3 | $57 |
| Bayer | 3 | $48 |
| Radius Health, Inc. | 3 | $46 |
| Embecta Corp. | 2 | $42 |
| Kyowa Kirin, Inc. | 2 | $42 |
| AbbVie | 2 | $35 |
| Tolmar, Inc. | 2 | $29 |
| Zealand Pharma US, Inc. | 1 | $20 |
| Rhythm Pharmaceuticals, Inc. | 1 | $19 |
| BD | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| EUSA Pharma (US) LLC | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
| BETA Bionics, Inc. | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| Merck | 1 | $13 |
| Alvogen Inc | 1 | $12 |
| Cequr Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$19,800
- MINIMED 780G$9,401
- t:slim X2 Insulin Pump with Control-IQ$5,600
- Minimed 770G System$3,925
- MINIMED 770G$2,100
- Korlym$116
How this compares
$47,829 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 253 | $320,473 |
| MounjaroTirzepatide | 132 | $174,845 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 54 | $144,010 |
| TrulicityDulaglutide | 97 | $127,806 |
| Tresiba Flextouch U-200Insulin Degludec | 41 | $85,293 |
| JardianceEmpagliflozin | 104 | $81,669 |
| Humalog Kwikpen U-200Insulin Lispro | 15 | $62,065 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 67 | $61,622 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 42 | $59,727 |
| Tresiba Flextouch U-100Insulin Degludec | 78 | $49,268 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 91 | $46,170 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 38 | $41,968 |
| Humalog Kwikpen U-100Insulin Lispro | 80 | $36,896 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 178 | $36,524 |
| Novolog FlexpenInsulin Aspart | 125 | $35,500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog, Fiasp, Tresiba | $1,095 | $379,308376 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $709 | $313,966316 claims |
| Boehringer IngelheimJardiance, Tradjenta | $352 | $101,040133 claims |
| AstraZenecaFarxiga | $123 | $26,79222 claims |
| MerckJanuvia | $13 | $21,72015 claims |
| Sanofi-aventis U.S. LLCLantus | $167 | $8,93531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Toledo
- Ashley SheskeyToledo$20K
- Jessica PalickiToledo$19K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.